Details for Patent: 8,242,294

Which drugs does patent 8,242,294 protect, and when does it expire?

Patent 8,242,294 protects KYBELLA and is included in one NDA.

This patent has sixty-two patent family members in thirty countries.

Summary for Patent: 8,242,294

Title:	Synthetic bile acid compositions and methods
Abstract:	Bile acids and related compositions and methods of synthesis and use. More specifically, deoxycholic acid and related compositions, said compositions being free of all moieties of animal origin and free of pyrogenic moieties.
Inventor(s):	Moriarty; Robert M. (Michiana Shores, IN), David; Nathaniel E. (Los Angeles, CA), Mahmood; Nadir Ahmeduddin (Calabasas, CA)
Assignee:	Kythera Biopharmaceuticals, Inc. (Calabasas, CA)
Application Number:	12/541,045
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,242,294
Patent Claim Types: see list of patent claims	Compound;

Drugs Protected by US Patent 8,242,294

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Kythera Biopharms	KYBELLA	deoxycholic acid	SOLUTION;SUBCUTANEOUS	206333-001	Apr 29, 2015	AP	RX	Yes	Yes				Y

International Family Members for US Patent 8,242,294

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	067440
Argentina	112325
Australia	2008265721
Brazil	PI0813140
Canada	2690841